Literature DB >> 9271080

Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.

B Weinhold1, A Bader, V Poli, U Rüther.   

Abstract

We have investigated the involvement of interleukin-6 (IL-6) in the induction of the gene encoding the acute-phase protein human C-reactive protein (hCRP). In transgenic mice the hCRP gene can be induced by lipopolysaccharide (LPS), but not by IL-6. In contrast, hCRP was inducible by IL-6 in primary human hepatocytes and in primary hepatocytes isolated from transgenic mice. To further evaluate the role of IL-6, we introduced the hCRP transgene into animals lacking endogenous IL-6 (IL-6-negative mice). Here, hCRP was not inducible by LPS, but was induced by a combination of LPS and IL-6. These results clearly demonstrate that IL-6 is necessary, but not sufficient, for the induction of hCRP expression. These animal models will allow further dissection of the cytokine network responsible for the regulation of the major human acute-phase reactant CRP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271080      PMCID: PMC1218603          DOI: 10.1042/bj3250617

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  62 in total

1.  Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates.

Authors:  P Mayer; K Geissler; M Ward; D Metcalf
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

Review 2.  The acute phase response.

Authors:  H Baumann; J Gauldie
Journal:  Immunol Today       Date:  1994-02

3.  IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo.

Authors:  S Marinkovic; G P Jahreis; G G Wong; H Baumann
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

Review 4.  Interleukin-6 in biology and medicine.

Authors:  S Akira; T Taga; T Kishimoto
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

5.  Disruption of the CNTF gene results in motor neuron degeneration.

Authors:  Y Masu; E Wolf; B Holtmann; M Sendtner; G Brem; H Thoenen
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

6.  The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.

Authors:  D P Ramji; A Vitelli; F Tronche; R Cortese; G Ciliberto
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

Review 7.  The action of interleukin 6 and leukaemia inhibitory factor on liver cells.

Authors:  H Baumann; S Marinkovic-Pajovic; K A Won; V E Jones; S P Campos; G P Jahreis; K K Morella
Journal:  Ciba Found Symp       Date:  1992

8.  The mouse C-reactive protein (CRP) gene is expressed in response to IL-1 but not IL-6.

Authors:  N O Ku; R F Mortensen
Journal:  Cytokine       Date:  1993-07       Impact factor: 3.861

9.  Inducible formation of liver tumors in transgenic mice.

Authors:  U Rüther; C Woodroofe; E Fattori; G Ciliberto
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

10.  Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

Authors:  V Poli; R Balena; E Fattori; A Markatos; M Yamamoto; H Tanaka; G Ciliberto; G A Rodan; F Costantini
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  27 in total

Review 1.  C-reactive protein, inflammation, and innate immunity.

Authors:  R F Mortensen
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  The evolving role of inflammation in obesity and the metabolic syndrome.

Authors:  Yong-Ho Lee; Richard E Pratley
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

3.  Intra-articular injection of hyaluronate and indomethacin in rabbits with antigen-induced arthritis.

Authors:  Yow-Jen Lo; Ming-Thau Sheu; Wen-Chi Tsai; Yun-Ho Lin; Jau-Le Li; Yu-Chih Liang; Chi-Ching Chang; Ming-Shium Hsieh; Chien-Ho Chen
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

4.  Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3.

Authors:  Alok Agrawal; Hyunjoo Cha-Molstad; David Samols; Irving Kushner
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

5.  Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene.

Authors:  B Weinhold; U Rüther
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

6.  Acetate-free blood purification can impact improved nutritional status in hemodialysis patients.

Authors:  Kazuhiro Matsuyama; Tadashi Tomo; Jun-ichi Kadota
Journal:  J Artif Organs       Date:  2011-02-19       Impact factor: 1.731

7.  Induction of glycosylation in human C-reactive protein under different pathological conditions.

Authors:  Tanusree Das; Asish K Sen; Tore Kempf; Sumit R Pramanik; Chhabinath Mandal; Chitra Mandal
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

8.  Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication.

Authors:  Michael I Koukourakis; Georgia Kambouromiti; Dimitra Pitsiava; Pelagia Tsousou; Maria Tsiarkatsi; George Kartalis
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

9.  Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.

Authors:  Hiroyuki Oka; Satoshi Ikeda; Seiji Koga; Yoshiyuki Miyahara; Shigeru Kohno
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

10.  Ibuprofen use is associated with reduced C-reactive protein and interleukin-6 levels in chronic spinal cord injury.

Authors:  Andrew Park; Dustin Anderson; Ricardo A Battaglino; Nguyen Nguyen; Leslie R Morse
Journal:  J Spinal Cord Med       Date:  2020-06-04       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.